What is the CVR number of Dragonfly Therapeutics CPH ApS?

Dragonfly Therapeutics CPH ApS is registered with CVR / Virk under CVR 41557958.

What is the revenue of Dragonfly Therapeutics CPH ApS?

Dragonfly Therapeutics CPH ApS reported revenue of DKK 25,8M in 2022.

How many employees does Dragonfly Therapeutics CPH ApS have?

Dragonfly Therapeutics CPH ApS employs 16 people as of the latest annual report.

Who is the CEO of Dragonfly Therapeutics CPH ApS?

Gary Arthur Martell is Chief Executive Officer of Dragonfly Therapeutics CPH ApS, in role since 2020.

Who is the chairman of Dragonfly Therapeutics CPH ApS?

Peter Andreas Nicolai Reumert Wagtmann chairs the board of Dragonfly Therapeutics CPH ApS, in role since 2020.

Where is Dragonfly Therapeutics CPH ApS headquartered?

Dragonfly Therapeutics CPH ApS's registered address is Baltorpvej 154.

Dragonfly Therapeutics CPH ApS

APSIn liquidation

CVR 41557958Baltorpvej 154Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 202016 employees

Revenue 2022

DKK 25,8M

-33% vs 2021

EBITDA margin

29.5%

+1% vs 2021

Equity ratio

-13.0%

Financial strength

Net profit 2022

DKK -8,1M

-490% vs 2021

EBITDA — year on yearDKK millions

Key figuresAnnual report 2022

Revenue	DKK 25,8M	-33%
EBITDA	DKK 7,6M	+1%
Net profit	DKK -8,1M	-490%
Total assets	DKK 45,8M	+59%
Equity	DKK -5,9M	-382%
Employees	16	—

Item	2021	2022
Revenue	38.742	25.842
Staff expenses	-31.006	-18.212
EBITDA	7.527	7.631
Depreciation & amort.	-4.622	-15.564
EBIT	2.904	-7.933
Net financials	-249	-282
Profit before tax	2.655	-8.216
Tax	589	-161
Net profit	2.066	-8.054

Item	2021	2022
Total assets	28.800	45.821
Equity	2.106	-5.948
Long-term debt	0	0
Short-term debt	26.533	51.769
Total debt	26.533	51.769

Name	Role	Member since
Former (4)
GA Gary Arthur Martell Chief Executive Officer	Chief Executive Officer	2020 – 2022
EB Esper Boel Chief Executive Officer	Chief Executive Officer	2020 – 2020
DT Dragonfly Therapeutics, Inc. Founder	Founder	2020 – 2023
SS Søren Sylvester Skjærbæk Unofficial title	Unofficial title	2022 – 2023

Name	Role	Member since
Former (1)
PA Peter Andreas Nicolai Reumert Wagtmann	Board of Directors	2020 – 2020

Shareholder	Type	Ownership	Votes	Since
Dragonfly Therapeutics, Inc.	Individual	100%	100%	2020

Person	Role here	Other companies
Gary Arthur Martell	Chief Executive Officer	0 companies
Esper Boel	Chief Executive Officer	0 companies
Dragonfly Therapeutics, Inc.	Founder	0 companies
Søren Sylvester Skjærbæk	Unofficial title	0 companies
Peter Andreas Nicolai Reumert Wagtmann	Board of Directors	0 companies